Introduction {#s1}
============

The interpretation of invasive coronary angiography (ICA) based on anatomic reference standard has been the sole diagnostic modality for coronary artery disease (CAD) for a long time \[[@R01]\]. However, fractional flow reserve (FFR) and stress cardiac magnetic resonance (SCMR) are now coming into more frequent use. Recent studies have demonstrated the discordance between FFR and ICA, especially at the extremes of the angiographic spectrum (stenosis less than 30% or greater than 90%) \[[@R01]\]. Thus, an assumption of functional relevance based merely on the angiographic appearance of stenosis in the absence of FFR can be misleading. FFR appears to be more precise for the depiction of lesion-specific ischemia but at the cost of radiation exposure and an invasive procedure. SCMR perfusion scans have been suggested as an alternative to guide clinical decision-making, particularly in cases of CAD with stenosis of 50-75% \[[@R02]\]. Our study adds to the existing literature by pooling all available data to determine the diagnostic accuracy of SCMR for diagnosing CAD severity when compared to the gold-standard FFR.

Materials and Methods {#s2}
=====================

Search strategy {#s2a}
---------------

A literature search for relevant articles was performed using PubMed, Ovid, Embase, clinicaltrials.gov, and Cochrane databases. There was no language or time restriction. The search strategies included various combinations of text-words and medical subject headings (MeSH) to generate two subsets of citations: one for magnetic resonance imaging using the terms such as "MRI", "magnetic resonance imaging", "magnetic resonance perfusion", "cardiac MRI", "SCMRI", "MR perfusion imaging"; the other for fractional flow reserve using terms such as "FFR", "fractional flow reserve", "flow reserve", "coronary flow reserve", and "coronary pressure reserve". The terms from the two subsets were combined in 1:1 combination using Boolean operators; and finally, results from all the possible combinations were downloaded into an EndNote library. Based on our research question, articles from the reference lists relevant to the clinical question were screened by an independent author.

Selection criteria and study collection {#s2b}
---------------------------------------

All observational (retrospective/prospective) studies and randomized control trials (RCT) on SCMR and FFR till September 30, 2019, were evaluated. Articles comparing the diagnostic accuracy of SCMR perfusion scan with FFR were included in the study. Papers with insufficient data, review articles, case reports, editorials, and conference papers were excluded.

Data extractions {#s2c}
----------------

Three authors independently screened titles and abstracts of all articles for relevance. A fourth author selected articles that met inclusion criteria. The full texts of articles that were potentially relevant to the study were screened by all the four authors to confirm eligibility. Baseline characteristics of the included population were reviewed, and data were collected for quality assessment to ensure study cohorts were statistically comparable. Risk factors for CAD, such as hypertension (HTN), hyperlipidemia (HLD), smoking, diabetes mellitus (DM), prior myocardial infarction (MI) and prior CAD were compared in each group of the included study to ensure comparability of the included population. Data were extracted into a combined Excel sheet. Disagreements were resolved by mutual consensus and after group discussion. The primary outcome was to determine the diagnostic accuracy of SCMR versus FFR for CAD severity.

Data and quality analysis {#s2d}
-------------------------

Raw data regarding the true and false positives and true and false negatives of each included study were obtained; and the combined measures of test accuracy (i.e., sensitivity, specificity, and diagnostic odds ratio (DOR)) for SCMR perfusion were calculated, keeping FFR as a standard. A bivariate model was obtained from data fitting. The parameters from the bivariate model were transformed into hierarchical summary receiver operating characteristic (HSROC) estimates. The area under the summary HSROC curve (AUC) was calculated to reveal the probability of accurately ranked diagnostic test values for a random pair of subjects (one with disease and one without disease). Chi-squared (χ^2^) tests were conducted to evaluate the heterogeneity of sensitivities and specificities among all studies. Subgroup analysis based on the resolution of SCMR and FFR cutoff points was performed to explore the potential heterogeneity factors using subgroup and meta-regression analysis. The statistical analysis was performed using the diagnostic accuracy statistical model on Stata and R mad package.

Quality of included studies {#s2e}
---------------------------

Quality of the included studies was assessed for potential bias and applicability concerns using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) standard questionnaire. The overall risk of bias and applicability concerns based on patient selection, index and reference standard, and the time duration between these tests were of low concern. Approximately 40% of studies either did not mention the duration or had more than 4 weeks difference between the aforementioned diagnostic tests. Only one study (Schuchlenz et al) had insufficient bias assessment data posing a 3% unknown bias risk to the index and reference standard tests \[[@R03]\] ([Fig. 1](#F1){ref-type="fig"}). Twenty-five percent of the studies did not specify the baseline characteristics of its subjects and were stratified under the high-risk selection bias group ([Fig. 2](#F2){ref-type="fig"}).

![Overall risk of bias on the QUADAS-2 tool of the included studies in our study. QUADAS-2: the Quality Assessment of Diagnostic Accuracy Studies.](cr-11-145-g001){#F1}

![Risk of bias on the QUADAS-2 tool of the individual studies included in our meta-analysis. QUADAS-2: the Quality Assessment of Diagnostic Accuracy Studies.](cr-11-145-g002){#F2}

Results {#s3}
=======

Search results and study characteristics {#s3a}
----------------------------------------

The initial search revealed 3,921 articles. After the removal of irrelevant and duplicate items, 238 articles were deemed relevant for full-text review. We further excluded 210 articles based on our selection criteria; and 28 studies were included for final analysis \[[@R03]-[@R30]\]. The preferred reporting items for systematic review and meta-analysis (PRISMA) flow diagram are shown in [Figure 3](#F3){ref-type="fig"}.

![PRISMA flow diagram showing the selection of studies from all databases. PRISMA: preferred reporting items for systematic review and meta-analysis.](cr-11-145-g003){#F3}

A total of 2,387 patients and 3,936 coronary vessels were included \[[@R03]-[@R30]\]. Mean age was 63 years. Seventeen studies used 0.8, and 11 articles used 0.75 as FFR cutoff. Studies using both 1.5T (18) and 3.0T (10) SCMR spatial resolution were included. Semi-quantitative data analysis was employed in 10 studies, quantitative in nine studies, while the method of data analysis was not specified in the remainder. A time interval of 4 weeks or less was present between SCMR and FFR in 16 of the included studies, more than 4 weeks in three studies, and not specified in eight studies. Subjects included in all the available studies had a variable prevalence of the baseline characteristics and comorbidities, including prior MI, CAD, DM, HTN, multivessel disease, and smoking. The detailed characteristics of the included studies are summarized ([Supplementary Material 1](#S1){ref-type="supplementary-material"}, [www.cardiologyres.org](http://www.cardiologyres.org)).

Patient-level pooled diagnostic accuracy {#s3b}
----------------------------------------

At the patient level, pooled sensitivity and specificity for perfusion SCMR were 0.86 (95% confidence interval (CI), 0.79 - 0.91) and 0.86 (95% CI, 0.82 - 0.90), respectively ([Fig. 4a, b](#F4){ref-type="fig"}). The DOR on a per-patient basis was 48.5 (95% CI, 23.52 - 100.41). The absolute AUC was 0.91, while partial AUC was 0.78 ([Fig. 5](#F5){ref-type="fig"}). The test for equality of sensitivities showed moderate to severe heterogeneity I^2^ = 88% (χ^2^ = 137.17, df = 16, P value ≤ 2 × 10^-16^), while moderate heterogeneity was observed among the studies selected for equality of pooled specificities I^2^ = 66% (χ^2^ = 50.59, df = 16, P value = 1.85 × 10^-5^).

![(a) Forest plot depicting individual and pooled sensitivity at the patient level. (b) Forest plot depicting individual and pooled specificity at the patient level.](cr-11-145-g004){#F4}

![Patient-level pooled diagnostic accuracy of CMR associated HROC vessel. CMR: cardiac magnetic resonance; HROC: hierarchical summary receiver operating characteristic.](cr-11-145-g005){#F5}

Coronary-territory pooled diagnostic accuracy {#s3c}
---------------------------------------------

At vessel level, SCMR showed an overall sensitivity of 0.82 (95% CI, 0.76 - 0.88), and specificity of 0.88 (95% CI, 0.84 - 0.94) compared to FFR ([Fig. 6a, b](#F6){ref-type="fig"}). The absolute AUC, partial AUC and DOR were 0.91, 0.85 and 37.95 (95% CI, 22.60 - 63.73), respectively ([Fig. 7](#F7){ref-type="fig"}). The test for equality of diagnostic accuracy showed moderate to severe heterogeneity among the studies selected for sensitivity (I^2^ = 89%, χ^2^ = 204.5, df = 21, P ≤ 2 × 10^-16^), and specificity (I^2^ = 85%, χ^2^ = 142.9, df = 21, P ≤ 2 × 10^-16^).

![(a) Forest plot depicting individual and pooled sensitivity at the vessel level. (b) Forest plot depicting individual and pooled specificity at the vessel level.](cr-11-145-g006){#F6}

![Vessel-level pooled diagnostic accuracy of CMR associated HROC. CMR: cardiac magnetic resonance; HROC: hierarchical summary receiver operating characteristic.](cr-11-145-g007){#F7}

Subgroup analysis based on FFR threshold {#s3d}
----------------------------------------

Pooled diagnostic accuracy was stratified based on the two reported FFR thresholds. At the vessel level, sensitivity and specificity at the lower FFR threshold (0.8) were significantly higher at 0.88 (95% CI, 0.84 - 0.91) and 0.89 (95% CI, 0.82 - 0.93), compared to 0.80 (0.68 - 0.88) and 0.87(0.82 - 0.91) for FFR at the higher threshold (0.75) ([Supplementary Material 2](#S2){ref-type="supplementary-material"}, [www.cardiologyres.org](http://www.cardiologyres.org)). The DOR of FFR at the higher threshold was only 29.71, almost half of the DOR for the lower (0.80) cutoff (62.37 (95% CI, 32 - 118).

At the patient level, however, the higher cutoff exhibited a higher net sensitivity, 0.90 (95% CI, 0.84 - 0.94) but lower specificity 0.82 (95% CI, 0.73 - 0.88) compared to the lower cutoff, where the sensitivity was 0.85 (95% CI, 0.76 - 0.91) and specificity was 0.90 (95% CI, 0.84 - 0.93) ([Supplementary Material 3](#S3){ref-type="supplementary-material"}, [www.cardiologyres.org](http://www.cardiologyres.org)). The overall DOR favored the lower FFR threshold (52.3, 95% CI, 20.81 - 131.47) vs. (43.96, 95% CI, 18.98 - 101.84).

Subgroup analysis based on SCMR resolution {#s3e}
------------------------------------------

At vessel level, the specificity of SCMR at higher resolution (0.90, 95% CI 0.866 - 0.93) was significantly greater compared to lower resolution (0.85, 95% CI, 0.79 - 0.89) ([Supplementary Material 4](#S4){ref-type="supplementary-material"}, [www.cardiologyres.org](http://www.cardiologyres.org)), while the sensitivity was marginally higher for the lower resolution (0.85 vs. 0.81). The overall DOR was superior for higher resolution SCMR (44, 95% CI, 20 - 95) compared to (33, 95% CI, 16 - 66) for 1.5T SCMR. At the patient level, the sensitivity and specificity were comparable at both resolutions ([Supplementary Material 5](#S5){ref-type="supplementary-material"}, [www.cardiologyres.org](http://www.cardiologyres.org)).

Meta-regression analysis based on comorbidities {#s3f}
-----------------------------------------------

Meta-regression analysis based on covariates such as age (higher or lower than 65 years) and CAD prevalence were performed. SCMR had high sensitivity and specificity at 0.92 and 0.94, respectively, for studies with CAD prevalence greater than 60%, compared with the sensitivity of 0.83, and specificity of 0.84 with prevalence of CAD less than 60% ([Supplementary Material 6](#S6){ref-type="supplementary-material"}, [www.cardiologyres.org](http://www.cardiologyres.org)). Corresponding values at the vessel level were lower ([Supplementary Material 6](#S6){ref-type="supplementary-material"}, [www.cardiologyres.org](http://www.cardiologyres.org)). For both younger and older populations, the SCMR sensitivity was 0.86, but a higher specificity was noted for the younger population (0.89 vs. 0.81) ([Table 1](#T1){ref-type="table"}). A comparison of patient and vessel level data has been shown in [Supplementary Material 7](#S4){ref-type="supplementary-material"} ([www.cardiologyres.org](http://www.cardiologyres.org)).

###### Meta-Regression Analysis on the Basis of CAD Prevalence and Age of the Patients in Included Studies

  Variable                  Sensitivity (95% CI)   Specificity (95% CI)   DOR
  ------------------------- ---------------------- ---------------------- ---------------
  Vessel level, MI \> 60%   0.84 (0.77 - 0.88)     0.86 (0.81 - 0.89)     32 (19 - 53)
  Patient, MI \> 60%        0.92 (0.88 - 0.94)     0.94 (0.92 - 0.96)     12 (10 - 33)
  Vessel level, MI \< 60%   0.81 (0.66 - 0.91)     0.88 (0.82 - 0.92)     34 (14 - 80)
  Patient, MI \< 60%        0.82 (0.74 - 0.89)     0.84 (0.81 - 0.87)     27 (15 - 50)
  Vessel level, Age \< 65   0.82 (0.74 - 0.88)     0.89 (0.85 - 0.92)     34 (14 - 80)
  Patient, Age \< 65        0.86 (0.79 - 0.91)     0.89 (0.85 - 0.93)     58 (26 - 126)
  Vessel level, Age \> 65   0.86 (0.71 - 0.94)     0.81 (0.72 - 0.88)     28 (12 - 67)

CAD: coronary artery disease; MI: myocardial infarction; 95% CI: 95% confidence interval; DOR: diagnostic odds ratio.

Discussion {#s4}
==========

If proven to have similar diagnostic efficacy, SCMR would be favorable to the current reference standard (FFR) due to its non-invasive nature, zero radiation exposure, and lower attenuation artifacts. Although myocardial perfusion SCMR has been possible for many years, the clinical sequence and data processing remain variable between centers. Our meta-analysis estimated the diagnostic performance of perfusion SCMR in patients with known or suspected CAD and focused on comparing diagnostic accuracies at varying spatial resolution and FFR thresholds. Our results reconcile the varying findings of previous studies and show high diagnostic accuracy of SCMR perfusion using FFR as a reference at patient level, with a sensitivity of 0.86 and specificity of 0.86. Subgroup analysis for the FFR threshold of lower (0.8) compared to higher (0.75) showed better sensitivity and specificity (about 90%) for the former. Further analysis showed that for higher spatial resolution of SCMR (3.0T), the sensitivity and specificity were also greater at 87% and 90%, respectively.

FFR is calculated as the ratio of hyperemic pressure difference across coronary lesions compared to theoretical maximum flow in healthy coronary arteries \[[@R31]\]. FFR is considered the gold standard and has been proven to improve event-free survival in coronary revascularization \[[@R32]\]. However, for all its benefits, it has yet to gain widespread acceptance due to the invasive nature of the procedure \[[@R32]\]. As mentioned above, SCMR perfusion imaging, which is a non-invasive procedure, would seek to allay the concerns around the risks of FFR while offering a similar diagnostic profile. Interpretation is based on coronary flow reserve (CFR), which is driven by the pressure gradient between systemic diastolic and left ventricular end-diastolic pressure at maximal vasodilation and under medication-induced stress. With vasodilator CMR (particularly using regadenoson, the most commonly used vasodilator currently), the perfusion defects are related to relative differences in blood flow between myocardium subtended by normal vs. stenotic coronary arteries \[[@R31]\]. The percentage of the ischemic territory serves as an indirect indicator of coronary artery stenosis, and is correlated against the findings of FFR \[[@R32]\].

On review of previously published meta-analyses, we noticed inconsistencies in the number of included studies. More contemporary studies did not always include all previously published data and had additional limitations due to outcome biases \[[@R02], [@R33]-[@R37]\]. Studies more stringent in their inclusion criteria, perhaps overestimated the diagnostic accuracy of SCMR owing to a positive selection bias. Danad et al (2016, four studies) reported a patient-based SCMR accuracy of greater than 90%; however, this was found to be lower at 87% in a 2019 study by Yang et al, which included a much higher number of studies (19) \[[@R02], [@R36]\]. Vessel-level sensitivity analysis showed a similar discordance across all included studies. A common limitation observed was a lack of stratification based on the different diagnostic thresholds for SCMR perfusion scans and FFR \[[@R34]-[@R37]\]. The study of Desai et al was the only one that used an FFR diagnostic threshold of 0.75 as opposed to the standard 0.80, hampering the sensitivity of the SCMR perfusion scan by classifying a significant population of patients having FFR of 0.75 - 0.80 as falsely "normal" \[[@R33]\]. Similarly, many included studies used 40-80% stenosis as inclusion criteria for stable CAD, when compared to the standard criteria of 50-75% stenosis. This would falsely classify subjects as having CAD compromising the sensitivity of SCMR ([Table 2](#T2){ref-type="table"}, \[[@R02], [@R33]-[@R37]\]). Moreover, differences in the contrast used across the studies also undermined the results; a few authors used exogenous contrast for stress images, while others advocated the utilization of the paramagnetic properties of deoxyhemoglobin as an endogenous contrast to identify loss of T2 flair in the blood oxygen level-dependent (BOLD) SCMR \[[@R36]\].

###### Characteristics, Outcomes and Limitations of Previously Reported Meta-Analyses

  Author                         Studies included   Sensitivity, specificity   Limitation     
  ------------------------------ ------------------ -------------------------- -------------- -------------------------------------------
  Desai et al, 2013 \[[@R33]\]   12                 89.1%, 84.9%               87.7%, 88.6%   Used 0.75 only
  Li et al, 2014 \[[@R34]\]      14                 90%, 87%                   89%, 86%       No stratification based on thresholds
  Jiang et al, 2016 \[[@R35]\]   20                 88%, 88%                   86%, 88%       No stratification based on thresholds
  Danad et al, 2017 \[[@R36]\]   4                  90%, 94%                   91%, 85%       No stratification based on thresholds
  Dai et al, 2016 \[[@R37]\]     21                 88%, 84%                   87%, 89%       No stratification based on MRI thresholds
  Yang et al, 2019 \[[@R02]\]    19                 87%, 87%                   85%, 89%       CAD 50-75%

CAD: coronary artery disease.

We aimed to close the gap in clinical practice and obtain consensus on the preferred approach towards the diagnosis of CAD severity, by performing a comprehensive analysis of all available data to address the aforementioned limitations.

The objective was to compare the efficacy of two investigative strategies for the management of patients with suspected CAD at the level of both higher and lower FFR thresholds and SCMR spatial resolution. Our overall results indicate that at a lower FFR threshold and higher spatial resolution, SCMR perfusion is comparable to invasive angiography supplemented by FFR measurements in guiding the management of patients with stable CAD. Our subgroup analyses showed a 4% rise in the vessel-level specificity of SCMR with an increase in its resolution from 1.5T to 3.0T and an 8% increase in specificity with the decreasing FFR threshold from 0.75 to 0.80. This improves the detection ability of SCMR perfusion to identify subendocardial ischemia. It also enables the detection of stress-mediated regional wall motion abnormalities at an earlier stage \[[@R36]\]. Given the comparable accuracy of SCMR perfusion scan to the current invasive reference standard (FFR), SCMR should be seen as an attractive non-invasive alternative to current diagnostic approaches.

This meta-regression analysis showed that sensitivity and specificity of SCMR differed among populations with differing pre-test probability of CAD, indicating patient selection based on presentation and risk stratification is essential. In the high prevalence group, SCMR findings were equivalent to FFR, and overall specificity was high at 94%. In these selected patients, SCMR can serve as a non-invasive substitute for FFR without significant loss in diagnostic accuracy. Interestingly, meta-regression based on age cutoff of 65 years showed similar sensitivity but an 8% lower specificity in the older population. One can argue that microvascular disease as a result of advancing age, smoking, and atherosclerosis can potentially affect SCMR perfusion imaging more than the FFR, and can have a detrimental effect on diagnostic accuracy. Stress CMR perfusion defects can be due to epicardial CAD and/or microvascular CAD. FFR on the other hand can be falsely in the "normal" range because of severe microvascular CAD, even in the presence of epicardial CAD. Thus, stress CMR is arguably more sensitive because unlike FFR, it "accounts for" the possibility of microvascular CAD, and the diagnostic accuracy comparisons may actually be affected because of a flawed reference standard (FFR).

Limitations {#s4a}
-----------

A few of the included studies performed a direct comparison of SCMR perfusion scan with FFR, an observation that may underscore the restricted availability of SCMR to advanced centers. Paradoxically, a lower rate of diagnostic accuracy is expected when SCMR becomes more widely available, leading to possible imprudent use.

We believe that the conceptual differences between these tests are irrefutable. FFR assumes static endothelial function on either side of the coronary lesion and an intact microcirculation. Thus, findings are reliable in large coronary arteries but are often underappreciated in microcirculation. In contrast, SCMR assesses the coronary vasculature in its entirety. FFR identifies the hemodynamic significance and functional relevance of coronary lesions, but gives no direct indication of the size of territory at risk of ischemia or its viability. SCMR, on the other hand, is a surrogate marker of coronary stenosis, an indirect measure of the degree of functional and anatomic coronary compromise based on the identification of myocardial ischemia. This technical discrepancy poses some theoretical risk of inconsistency and unreliability between the two diagnostic modalities.

Conclusions {#s4b}
-----------

SCMR can be used as a confirmation test for patients with a high pretest probability of CAD and as an exclusionary test for low-risk patients due to its high specificity and sensitivity compared to FFR, respectively. A lower FFR threshold of 0.8 and a higher SCMR resolution of 3.0T, in particular, were associated with the highest diagnostic accuracy. SCMR represents advances over FFR in the detection of CAD severity, due to its non-invasive nature, being readily available and offering a comparable sensitivity and specificity.
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